Beat COVID-19 - Observational Trial

Status unconfirmed

Conditions studied: COVID-19

In brief

JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients with COVID-19. We aim to accomplish this by obtaining self-reported historical and longitudinal data from study participants.

Key facts

Study ID

NCT04337762

Run by

Beat COVID LLC

People needed

100000

Starts

2020-04-06

Expected to finish

2021-07-01

Last updated by the study team

2020-04-09

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults residing in the United States aged 18 years or older proficient in understanding and reading the English language who wish to participate in the fight against COVID-19 by providing self-reported health information.
• Ability to complete electronic informed consent process.
• Ability to use the internet and check email regularly.
• Consent to provide a HIPAA waiver of health information to share protected health information.

You may not qualify if…

• Inability to provide regular updates to their health status when contacted by the BEAT COVID study personnel via email or SMS.

Where it is running

• Beat COIVD, LLC — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.